Clinical Trial Detail

NCT ID NCT04171700
Title A Study to Evaluate Rucaparib in Patients With Solid Tumors and With Deleterious Mutations in HRR Genes (LODESTAR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Clovis Oncology, Inc.
Indications

Advanced Solid Tumor

Therapies

Rucaparib

Age Groups: senior adult

Additional content available in CKB BOOST